Personalized therapy in leukemia: a case study

Personalized therapy in leukemia: a case study

VJHemOnc

1 year
237 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
An improved understanding of the disease biology of leukemia has driven personalized therapy that has helped lower the risk of relapse in patients. Here, Patrick Kiel, PharmD, BCOP, BCPS, of Indiana University Simon Cancer Center, Indianapolis, IN, discusses a case study in which the patient was identified with PD-L1 expression and a BRAF V600E mutation, and how these identifications helped improve the treatment outcome. Dr Kiel was speaking at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO.
Up Next Autoplay
CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology
CML Ponatinib vs Bosutinib: What is Next for Research? #ASH19 @TakedaOncology
Category: Chronic Myelogenous Leukemia
23 Views
ash 1 month
CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology
CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology
Category: Chronic Myelogenous Leukemia
63 Views
ash 1 month
Brentuximab Vedotin with Chemotherapy #ASH19
Brentuximab Vedotin with Chemotherapy #ASH19
Category: Chronic Myelogenous Leukemia
7 Views
ash 1 month
Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
Modeling Responses When Testing Less Frequently Than Monthly After Stopping Therapy
Category: Chronic Myelogenous Leukemia
14 Views
iCMLf 1 month
Perspectives on the Future of CML
Perspectives on the Future of CML
Category: Chronic Myelogenous Leukemia
44 Views
iCMLf 1 month
Re-evaluating TKI in CML Patients During Pregnancy
Re-evaluating TKI in CML Patients During Pregnancy
Category: Chronic Myelogenous Leukemia
6 Views
iCMLf 1 month
CML and Pregnancy
CML and Pregnancy
Category: Chronic Myelogenous Leukemia
13 Views
iCMLf 1 month
Treating CML & Myelofibrosis Patients
Treating CML & Myelofibrosis Patients
Category: Chronic Myelogenous Leukemia
321 Views
imedex 1 year
Resistance/intolerance to second generation TKIs in CML: what to do next?
Resistance/intolerance to second generation TKIs in CML: what to do next?
Category: Chronic Myelogenous Leukemia
157 Views
VJHemOnc 1 year
Update on ENESTop: TFR in CML after discontinuing nilotinib
Update on ENESTop: TFR in CML after discontinuing nilotinib
Category: Chronic Myelogenous Leukemia
149 Views
VJHemOnc 1 year